Feb 14 (Reuters)-
Shin Nippon Biomedical Laboratories Ltd
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Dec 31, 2017 Dec 31, 2016 Mar 31, 2018
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 11.50 11.55 16.25
(-0.5 pct) (+10.8 pct) (-5.8 pct)
Operating loss 1.18 loss 2.10 loss 1.10
Recurring loss 921 mln loss 1.83 loss 1.22
Net loss 1.94 loss 1.78 loss 1.50
EPS loss 46.63 yen loss 43.33 yen loss 36.02 yen
Ann Div NIL
-Q2 div NIL NIL
-Q4 div NIL
NOTE - Shin Nippon Biomedical Laboratories Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=2395.T
((Tokyo Headline News Desk +813 6441 1812))